Pharmaceutical News

Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead Clinical stage outfit, Destiny Pharma, has announced an update of its late-stage clinical assets, providing a positive summary of prospects for the year ahead. Indeed, it is safe to say that the innovative biotechnology company has much to be optimistic about, with
0 Comments
A recent study published in the journal The Lancet Regional Health (Europe) shows how smoking can be linked with increased social isolation and loneliness in older individuals, implying it can have detrimental effects on several different aspects of their psychosocial health. Study: Relationship of smoking with current and future social isolation and loneliness: 12-year follow-up
0 Comments
Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required. Kidney Research UK and the Stoneygate Trust have announced new Manchester-based research programme dedicated to the study and treatment of the rare kidney condition, Alport syndrome, which is to begin work in early 2022. The Manchester-based research hub aims
0 Comments
Ever since the emergence and rapid spread of severe acute respiratory syndrome coronavirus (SARS-CoV) in southern China in 2002, scientists have considered coronaviruses to be a potential threat to humans. Another member of the coronavirus family, namely, Middle East respiratory syndrome coronavirus (MERS-CoV), showed high transmission and mortality rate; however, it did not spread across
0 Comments
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.  This has led many in the UK to wonder – if Djokovic had been heading for SW19 this winter, what would be the outcome? While the sports star has remained elusive about his vaccination
0 Comments
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation to include the advancement of new innovations for HIV and malaria treatment. The new commitment from the Bill & Melinda Gates Foundation supports the development of Vir Biotech’s ‘vaccinal antibody’ technology, a significant tool in combatting
0 Comments
Since December 2019, Wuhan, China, has been conducting influenza and related disease monitoring, and a number of cases of viral pneumonia have been discovered, all of which have been diagnosed as viral pneumonia or pulmonary infection. The World Health Organization (WHO) designated it a novel coronavirus (2019-nCoV) on January 12, 2020. The coronavirus Research Group dubbed
0 Comments
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from the trial immunogenicity and safety trial, D7220C00001, reveal that the vaccine generated a higher antibody response against the Omicron variant as well as others, including Beta, Delta, Alpha, and Gamma, according to Reuters. An increased
0 Comments
Scientists have worked at an unprecedented speed to develop vaccines to fight against the ongoing coronavirus disease 2019 (COVID-19) pandemic. This pandemic has been caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA virus belonging to the family Coronaviridae. Study: Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. Image Credit: NIAID Background It
0 Comments
When male workers believe their gender status is threatened, they are more likely than their female counterparts to engage in deviant behavior such as lying, cheating or stealing in the workplace, new research suggests. They also become less helpful to co-workers and less willing to collaborate on organizational initiatives, said Oregon State University’s Keith Leavitt,
0 Comments
The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide. Oxford University has joined a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug
0 Comments
Researchers at Penn Medicine have discovered a new, more effective method of preventing the body’s own proteins from treating nanomedicines like foreign invaders, by covering the nanoparticles with a coating to suppress the immune response that dampens the therapy’s effectiveness. When injected into the bloodstream, unmodified nanoparticles are swarmed by elements of the immune system
0 Comments
Dr. Michael Wenzel from the Department of Epileptology at the University Hospital Bonn has received a coveted Starting Grant from the European Research Council (ERC). With the associated funding of 1.5 million euros for the next five years, the neurologist wants to study novel light-activated drugs with antiepileptic effects investigating how they can help against
0 Comments
The companies share the goal of furthering knowledge around GPCR biology in immune cells in order to better understand a range of immune system disorders. Sosei Group Corporation and Verily, an Alphabet precision health company, announced that they have entered into a strategic research collaboration. This agreement brings together the capabilities of Verily’s immune profiling
0 Comments
In a recent article published on the bioRxiv* preprint server, researchers demonstrate that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant grows rapidly in human primary nasal epithelial cultures. Study: The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. Image Credit:
0 Comments
The platform integrates primary human tissue samples into early target and drug discovery research. Sanofi and Exscientia have announced a research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology. This will utilise Exscientia’s end-to-end AI-driven platform, which uses real patient samples. By using a platform which
0 Comments